SIV

An antibody used to treat Crohn’s disease controls simian immunodeficiency virus infection in Rhesus macaques by blocking T cell migration to the gut.

A strain of HIV that has afflicted more than 100,000 people emerged from gorillas.

Regular injections of an antiretroviral drug protects macaques from simian-human immunodeficiency virus infection, researchers report.

A cytomegalovirus-based vaccine eliminated simian immunodeficiency virus from rhesus macaques, raising hopes of a similarly effective HIV vaccine.

Monkeys infected with simian immunodeficiency virus have a higher diversity of gut viruses, pointing to a possible role of the virome in SIV pathogenesis.

A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys